David Erritzoe

37PUBLICATIONS
86CO-AUTHORS
Social and affective neuroscienceMedical biotechnology diagnostics (incl. biosensors)Molecular medicineSensory processes, perception and performanceClinical pharmacology and therapeutics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|May 05, 2026
Human brain changes after first psilocybin use.

|Mar 21, 2026
Detecting neuroplastic effects induced by ketamine in healthy human subjects: A multimodal approach.

Claudio Agnorelli, Joseph Peill, Gabriela Sawicka

|Feb 16, 2026
A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial.

David Erritzoe, Tommaso Barba, Tiffanie Benway

|Nov 19, 2025
Negative affective bias in depression following treatment with psilocybin or escitalopram - a secondary analysis from a randomized trial.

Marieke A G Martens, Bruna Giribaldi Cunha, David Erritzoe

|Nov 01, 2025
Dissociable effects of LSD and MDMA on striato-cortical connectivity in healthy subjects.

Natalie Ertl, Imran Ashraf, Lisa Azizi

|Oct 28, 2025
A long, strange trip: Ketamine treatment in psychiatry.

David J Nutt, Celia Morgan, David Erritzoe

Pageof 7

Frequent Collaborators

18 joint publications

Robin Lester Carhart-Harris

13 joint publications

David Nutt

5 joint publications

Christopher Timmermann

5 joint publications

Tommaso Barba